Karl Hård
Contacto de Relaciones con Inversores en EGETIS THERAPEUTICS AB .
Cargos activos de Karl Hård
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
EGETIS THERAPEUTICS AB | Contacto de Relaciones con Inversores | 01/02/2022 | - |
Public Communications Contact | 01/02/2022 | - |
Historial de carrera de Karl Hård
Antiguos cargos conocidos de Karl Hård.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
KIADIS PHARMA N.V. | Contacto de Relaciones con Inversores | 05/09/2017 | 31/12/2018 |
Public Communications Contact | 05/09/2017 | 31/12/2018 | |
REDX PHARMA PLC | Contacto de Relaciones con Inversores | 08/09/2016 | 02/07/2017 |
Public Communications Contact | 08/09/2016 | 02/07/2017 | |
University of Leiden | Corporate Officer/Principal | - | - |
ASTRAZENECA PLC | Public Communications Contact | - | - |
Formación de Karl Hård.
University of Utrecht | Doctorate Degree |
University of Helsinki | Graduate Degree |
Estadísticas
Internacional
Países Bajos | 4 |
Reino Unido | 3 |
Finlandia | 2 |
Operativa
Public Communications Contact | 4 |
Investor Relations Contact | 3 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
ASTRAZENECA PLC | Health Technology |
REDX PHARMA PLC | Health Technology |
EGETIS THERAPEUTICS AB | Health Technology |
Empresas privadas | 1 |
---|---|
Kiadis Pharma NV
Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Kiadis Pharma NV engages in pharmaceutical development of cell-based immunotherapy products in the field of diseases of the blood building system. Its lead product is the ATIR101. The company was founded in 1997 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
- Bolsa de valores
- Insiders
- Karl Hård
- Experiencia